IRIS
MORETTA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60.349
AS - Asia 5.365
NA - Nord America 5.108
Continente sconosciuto - Info sul continente non disponibili 568
SA - Sud America 509
AF - Africa 101
OC - Oceania 7
Totale 72.007
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.332
US - Stati Uniti d'America 4.668
SG - Singapore 2.380
CN - Cina 1.382
VN - Vietnam 833
FR - Francia 496
BR - Brasile 310
BD - Bangladesh 242
HK - Hong Kong 189
CA - Canada 171
FI - Finlandia 109
DE - Germania 98
MX - Messico 83
GB - Regno Unito 79
JP - Giappone 69
CH - Svizzera 66
AR - Argentina 63
CR - Costa Rica 44
IN - India 40
JM - Giamaica 40
CO - Colombia 39
ID - Indonesia 35
NL - Olanda 35
EC - Ecuador 32
PH - Filippine 32
IQ - Iraq 31
HN - Honduras 20
VE - Venezuela 20
GT - Guatemala 18
ZA - Sudafrica 17
ES - Italia 16
PK - Pakistan 16
RU - Federazione Russa 16
CL - Cile 15
TH - Thailandia 15
TT - Trinidad e Tobago 15
SV - El Salvador 14
IE - Irlanda 13
MA - Marocco 12
PY - Paraguay 12
NI - Nicaragua 11
PL - Polonia 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
PE - Perù 10
PR - Porto Rico 10
UA - Ucraina 10
KE - Kenya 9
MY - Malesia 9
SC - Seychelles 9
DZ - Algeria 8
EG - Egitto 7
RO - Romania 7
TR - Turchia 7
TW - Taiwan 7
BG - Bulgaria 6
JO - Giordania 6
NP - Nepal 6
PT - Portogallo 6
TN - Tunisia 6
AL - Albania 5
AT - Austria 5
AU - Australia 5
PS - Palestinian Territory 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
GA - Gabon 4
IR - Iran 4
OM - Oman 4
SN - Senegal 4
BY - Bielorussia 3
CG - Congo 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EE - Estonia 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MM - Myanmar 3
NO - Norvegia 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BF - Burkina Faso 2
CD - Congo 2
DJ - Gibuti 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
GF - Guiana Francese 2
GR - Grecia 2
IL - Israele 2
MK - Macedonia 2
ML - Mali 2
RS - Serbia 2
SI - Slovenia 2
TL - Timor Orientale 2
Totale 71.407
Salva come PNG Salva come JPEG
Città #
Genova 40.047
Genoa 10.833
Rapallo 4.521
Vado Ligure 3.391
San Jose 1.433
Singapore 1.105
Lauterbourg 460
Ashburn 399
Ho Chi Minh City 246
New York 220
Beijing 195
Hanoi 176
Hong Kong 173
Santa Clara 135
Helsinki 109
Bordighera 108
Los Angeles 93
Milan 86
Frankfurt am Main 84
Council Bluffs 76
Phoenix 76
Chicago 66
Tokyo 66
Zurich 66
Dallas 51
Mexico City 50
Rome 45
Haiphong 39
Da Nang 36
San José 34
Tianjin 33
Toronto 28
Atlanta 27
Montreal 27
Houston 26
San Francisco 26
Des Moines 23
Kingston 23
Brasília 22
Philadelphia 22
Amsterdam 21
Buffalo 21
Brooklyn 18
Naples 18
Charlotte 17
Shanghai 17
Washington 17
Biên Hòa 16
City of London 16
Baghdad 15
London 15
Orem 15
Queens 15
Miami 14
São Paulo 14
The Bronx 14
Guatemala City 13
Bangkok 12
Columbus 12
Dublin 12
Hải Dương 12
Jacksonville 12
Ninh Bình 12
Palermo 12
Pittsburgh 12
San Salvador 12
Cardiff 11
Denver 11
Mumbai 11
Seattle 11
Turin 11
Florence 10
Medellín 10
Minneapolis 10
Princeton 10
San Pedro Sula 10
Bologna 9
Catania 9
Johannesburg 9
Managua 9
St Louis 9
Tashkent 9
Can Tho 8
Chaguanas 8
Dhaka 8
Guayaquil 8
Jakarta 8
Nairobi 8
Valenza 8
Akron 7
Baltimore 7
Bogotá 7
Cincinnati 7
Fresno 7
Guangzhou 7
Hamilton 7
Jersey City 7
Las Vegas 7
Manchester 7
Memphis 7
Totale 65.352
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 271
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 250
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 247
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 247
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 246
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 234
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 233
Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. 231
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 229
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 226
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. 225
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 224
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 222
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 222
2B4 functions as a co-receptor in human NK cell activation 220
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 213
NK/DC crosstalk in anti-viral response. 213
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 212
Features of Memory-Like and PD-1+ Human NK Cell Subsets 211
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 210
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 207
Bridging innate NK cell Functions with Adaptive Immunity. 206
Human NK receptors: from the molecules to the therapy of high risk leukemias. 206
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 205
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 205
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 203
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 200
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 198
X-linked lymphoproliferative disease: the dark side of 2B4 function. 195
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 195
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 195
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 194
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 194
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 194
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 194
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 193
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 193
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 193
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 192
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 191
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 191
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 190
Function and specificity of human natural killer cell receptors. 189
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 189
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 188
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 188
Markers and function of human NK cells in normal and pathological conditions 187
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 187
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 185
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 185
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 185
NK cells and their receptors during viral infections. 184
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 182
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 181
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 180
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 180
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 180
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 179
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 179
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 178
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). 178
Human NK cells and NK receptors 178
Multi-directional cross-regulation of NK cell function during innate immune responses. 177
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 177
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 177
Natural killer cells and dendritic cells: rendezvous in abused tissues. 176
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 176
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 176
A high-resolution view of NK-cell receptors: structure and function. 176
Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages 176
KIR and KIR ligand polymorphism: a new area for clinical applications? 176
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 176
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 176
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 175
Alloreactive natural killer cells in targeting high-risk leukaemias. 175
CIS is a negative regulator of IL-15-mediated signals in NK cells 175
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. 175
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 174
Stimulatory receptors in NK and T cells. 173
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 173
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 173
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion 173
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 172
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 172
Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). 172
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. 171
Cellular ligands for activating NK receptors 171
A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. 171
Impact of HCMV Infection on NK Cell Development and Function after HSCT. 171
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 171
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 171
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. 170
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 170
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 169
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. 167
Unravelling natural killer cell function: triggering and inhibitory human NK receptors. 166
IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens. 165
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients 165
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 165
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 165
Totale 19.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.087
article - articoli 195.439
book - libri 0
conference - conferenze 8.838
curatela - curatele 0
other - altro 0
patent - brevetti 13.203
selected - selezionate 0
volume - volumi 2.607
Totale 440.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.431 0 0 640 659 277 297 379 1.421 220 550 259 729
2022/20235.521 631 317 52 576 895 1.118 2 397 1.014 34 410 75
2023/20242.479 123 419 69 287 229 353 107 163 194 77 145 313
2024/20257.516 126 644 317 488 1.280 710 677 986 319 341 665 963
2025/202613.053 1.443 347 787 1.044 1.610 1.553 2.356 597 830 1.208 539 739
2026/20272.830 1.488 325 1.017 0 0 0 0 0 0 0 0 0
Totale 72.007